# Advancing KRAS G12C-Targeted Therapies in NSCLC: Current Evidence and Future Directions Page: https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions Text version: https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions.md Podcast: [Decera Clinical Education Oncology Podcast](https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999) Published: 2026-03-09T17:28:43+00:00 Episode link: https://oncologypodcast.simplecast.com/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions-b5W8lj1w Audio file: https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/f66e748b-9c41-4a1f-b7ad-ef0bbde021f4/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=f66e748b-9c41-4a1f-b7ad-ef0bbde021f4&feed=GlfUTtJq Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions Duration seconds: 1004 ## Resource In this episode, 2 experts discuss the evolving role of KRAS G12C inhibitors in non-small-cell lung cancer (NSCLC), including the clinical impact of first-generation therapies and challenges related to resistance. They also explore emerging next-generation inhibitors and combination strategies that may expand treatment options and improve patient outcomes. ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.